That’s the claim anyway.
From MIT Technology Review:
“The latest advancement in anti-aging therapies hardly sounds like modern medicine at all. Ambrosia, a startup based in Monterey, California, is launching a clinical trial to inject the blood of young people into just about anyone aged 35 and up—if they’re willing to pay $8,000.
Young-to-old blood transfusions hit the limelight in 2014 when Harvard Stem Cell Institute researcher Amy Wagers discovered that the blood of young mice improved muscle, heart, and brain function in older mice.”
Source: The Next Health Fad? Blood Transfusions from Young People
If this pans out, I bet it can be done for much less than $8,000.
Thanks for posting! I’m definitely excited to see the results of this fascinating study.